Search

Search Results
Results 24271 - 24280 of 24541 for Acid
  • Drug - 21 Jun 2024
    Consumer Medicine Information (CMI) about Luveris intended for persons living in Australia.
  • Drug - 17 Jun 2024
    Consumer Medicine Information (CMI) about Sandostatin intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Oncaspar LYO intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Spiriva Respimat (with dose indicator) intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Spiolto Respimat (with dose indicator) intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Spevigo intended for persons living in Australia.
  • Drug - 16 May 2024
    Consumer Medicine Information (CMI) about DBL Gemcitabine Injection intended for persons living in Australia.
  • White Paper - 14 May 2024
    This article explores the innovative approach of Antibody-Drug Conjugates (ADCs) in cancer therapy, highlighting their targeted delivery of cytotoxic drugs to cancer cells.
  • Drug - 14 May 2024
    Consumer Medicine Information (CMI) about Minims Lidocaine HCl/Fluorescein Sodium intended for persons living in Australia.
  • Drug - 9 May 2024
    Consumer Medicine Information (CMI) about Sodium Chloride Injection and Intravenous Infusion intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.